Global Vaccine Vials Market Size, Share, Industry Trends, Forecast 2023-2028

Comments · 29 Views

The global vaccine vials market size reached US$ 576.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,056.0 Million by 2028, exhibiting a growth rate (CAGR) of 10.30% during 2023-2028.

Global Vaccine Vials Market Overview 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Vaccine Vials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global vaccine vials market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global vaccine vials market size reached US$ 576.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,056.0 Million by 2028, exhibiting a growth rate (CAGR) of 10.30% during 2023-2028.

Vaccine vials are compact, hermetically sealed receptacles crafted to securely and effectively store and transport vaccines. Typically constructed from glass for its inert properties and sterilization maintenance, these vials often feature calibrated markings to facilitate precise dosage measurement and administration. By preventing the ingress of air and moisture, they safeguard vaccine stability. The interior of these vials is meticulously kept sterile to ensure the vaccines remain untainted. Offering protection against light, heat, and air exposure, they play a crucial role in preserving the potency of vaccines over time. Widely employed in mass immunization campaigns, they guarantee the safe conveyance and administration of vaccines to the population. Furthermore, healthcare professionals utilize them for storing and dispensing vaccines during routine vaccinations and healthcare visits. Additionally, these vials find application in laboratories and pharmaceutical companies for the research, development, and testing of new vaccines.

Request a Sample Report:- https://www.imarcgroup.com/vaccine-vials-market/requestsample

Global Vaccine Vials Market Trends and Drivers:

The market is experiencing growth primarily due to the expanding aging population and the increasing prevalence of various diseases. The rise of personalized medicine and biopharmaceuticals is also contributing to a positive market outlook. Furthermore, there is a noticeable trend towards reducing wastage and optimizing vaccine distribution, which is impacting the market positively. Advancements in vaccine technologies are driving the demand for specialized vials capable of maintaining the stability and efficacy of complex vaccine formulations. The expanding healthcare infrastructure is creating a greater need for vaccine storage and distribution systems, supported by the global focus on improving healthcare accessibility. Stringent regulatory guidelines and quality standards for vaccine packaging are prompting manufacturers to invest in high-quality vials meeting these requirements. Biopharmaceutical research advancements, particularly in novel vaccines and therapies like mRNA-based vaccines, necessitate specialized vials to protect delicate formulations and ensure efficacy. The integration of smart features, such as radio frequency identification (RFID) tracking systems and temperature-sensitive labels, into vaccine vials is further propelling market growth. These innovations enable monitoring and ensure the integrity of vaccines during transit and storage, enhancing the reliability and safety of vaccine distribution. Partnerships and collaborations between pharmaceutical companies and vial manufacturers are on the rise, aiming to streamline the supply chain for a steady and efficient flow of vaccines to end-users. Additionally, the emergence of e-commerce and direct-to-consumer (D2C) distribution channels for vaccines is contributing to market growth.

Global Vaccine Vials Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Anhui Huaxin Medicinal Glass Products Co. Ltd., Berlin Packaging LLC, Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co. Ltd., JOTOP Glass, Richland Glass Company, Schott AG, Shandong Pharmaceutical Glass Co. Ltd. and Stevanato Group.

The report segmented the market on the basis of region, type, material, capacity and application.

Breakup by Type:

  • Multi Dose
  • Single Dose

Breakup by Material:

  • Glass
  • Polymer

Breakup by Capacity:

  • 10ml
  • 20ml
  • 2ml
  • 3ml
  • 5ml

Breakup by Application:

  • Preventive Vaccine
  • Therapeutic Vaccine

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

Read more
Comments